Hostname: page-component-5c6d5d7d68-vt8vv Total loading time: 0.001 Render date: 2024-08-14T23:49:37.342Z Has data issue: false hasContentIssue false
  • English
  • Français

Infection Control and Cost Control in the Era of Managed Care

Published online by Cambridge University Press:  02 January 2015

David P. Calfee  and
Barry M. Farr
David P. Calfee
Affiliation:
Department of Medicine, University of Virginia Health System, Charlottesville, Virginia
Barry M. Farr*
Affiliation:
Department of Medicine, University of Virginia Health System, Charlottesville, Virginia
*
Box 800473 Cobb Hall, University of Virginia Health System, Charlottesville, VA 22908
Get access Rights & Permissions [Opens in a new window]

Extract

During the past several years, major changes have occurred in the way in which health care is provided and financed. One of the outcomes of these changes has been a greater emphasis on providing quality health care at a low cost. This has led many healthcare facilities to question the necessity of all expenditures and to reduce spending when at all possible. Many healthcare facilities have solicited the services of consulting groups to provide recommendations regarding cost-containment strategies appropriate for their particular institution.

Type
Readers' Forum
Information
Infection Control & Hospital Epidemiology , Volume 23 , Issue 7 , July 2002 , pp. 407 - 410
Copyright
Copyright © The Society for Healthcare Epidemiology of America 2002

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1.Haley, RW, Culver, DH, White, JW, et al. The efficacy of infection surveillance and control programs in preventing nosocomial infections in US hospitals. Am J Epidemiol 1985;121:182–205.Google Scholar
2.Scheckler, WE, Brimhall, D, Buck, AS, et al. Requirements for infrastructure and essential activities of infection control and epidemiology in hospitals: a consensus panel report. Infect Control Hosp Epidemiol 1998;19:114–124.CrossRefGoogle ScholarPubMed
3.Miller, PJ, Farr, BM, Gwaltney, JM. Economic benefits of an effective infection control program: case study and proposal. Rev Infect Dis 1989; 11:284–288.Google Scholar
4. Anonymous. Recommendations for prevention of HIV transmission in health-care settings. MMWR 1987;36:1S–18S.Google Scholar
5. Occupational Exposure to Bloodborne Pathogens, 29 C.F.R. Part 1910.1030 (1991).Google Scholar
6. Anonymous. Guidelines for preventing the transmission of Mycobacterium tuberculosis in healthcare facilities, 1994. MMWR 1994;43:1–132.Google Scholar
7. Occupational exposure to tuberculosis; proposed rule, 29 C.F.R. Part 1910 (1997).Google Scholar
8.Friedman, C, Barnette, M, Buck, AS, et al. Requirements for infrastructure and essential activities of infection control and epidemiology in out-of-hospital settings: a consensus panel report. Infect Control Hosp Epidemiol 1999;20:695–705.Google Scholar
9. Anonymous. Recommendations for preventing the spread of vancomycin resistance: recommendations of the Hospital Infection Control Practices Advisory Committee (HICPAC). MMWR 1995;44:1–13.Google Scholar
10.Garner, JS, Hospital Infection Control Practices Advisory Committee. Guideline for isolation precautions in hospitals. Infect Control Hosp Epidemiol 1996;17:54–80.CrossRefGoogle ScholarPubMed
11.Calfee, DP, Giannetta, ET, Farr, BM. Effective control of VRE colonization using CDC recommendations for detection and isolation. Presented at the 38th Annual Meeting of the Infectious Diseases Society of America; September 7-10,2000; New Orleans, LA Abstract 21.Google Scholar
12.Jernigan, JA, Clemence, MA, Stott, GA, et al. Control of methicillin-resistant Staphylococcus aureus at a university hospital: one decade later. Infect Control Hosp Epidemiol 1995;16:686–696.Google Scholar
13.Ostrowsky, BE, Trick, WE, Sohn, AH, et al. Control of vancomycin-resistant Enterococcus in health care facilities in a region. N Engl J Med 2001;344:1427–1433.Google Scholar
14.Seutens, C, Ronveaux, O, Jans, B, Carsauw, H. Mortality impact of antibiotic resistance in Belgian intensive care units (ICUs). Presented at the Ninth Annual Meeting of the Society for Healthcare Epidemiology of America; April 18-20,1999; San Francisco, CA Abstract 27.Google Scholar
15.Stosor, V, Peterson, LR, Postelnick, M, Noskin, GA. Enterococcus faecium bacteremia: does vancomycin resistance make a difference? Arch Intern Med 1998;158:522–527.Google Scholar
16.Linden, PK, Pasculle, AW, Manez, R, et al. Differences in outcomes for patients with bacteremia due to vancomycin-resistant Enterococcus faecium or vancomycin-susceptible E. faecium. Clin Infect Dis 1996;22:663–670.Google Scholar
17.Jernigan, JA, Hadziyannis, SC. Vancomycin-resistant Enterococcus faecium (VRE) bacteremia (B) in severely neutropenic patients. Presented at the 36th Annual General Meeting of the Interscience Conference on Antimicrobial Agents and Chemotherapy; September 1996; New Orleans, LA Abstract J8.Google Scholar
18.Bhavnani, SM, Drake, JM, Forrest, A, et al. A nationwide, multicenter, case-control study comparing risk factors, treatment, and outcome for vancomycin-resistant and susceptible enterococcal bacteremia. Diagn Microbiol Infect Dis 2000;36:145–158.CrossRefGoogle ScholarPubMed
19.Lucas, GM, Lechtzin, N, Puryear, DW, Yau, LL, Flexner, CW, Moore, RD. Vancomycin-resistant and vancomycin-susceptible enterococcal bacteremia: comparison of clinical features and outcomes. Clin Infect Dis 1998;26:1127–1133.Google Scholar
20.Abramson, MASexton, DJ. Nosocomial methicillin-resistant and methicillin-susceptible Staphylococcus aureus primary bacteremia: at what costs? Infect Control Hosp Epidemiol 1999;20:408–411.Google Scholar
21.Song, X, Plaut, D, Perl, T. Vancomycin resistant enterococci nosocomial bloodstream infections: the attributable mortality, length of stay, and extra costs. Presented at the 37th Annual Meeting of the Infectious Diseases Society of America; November 18-21, 1999; Philadelphia, PA Abstract 500.Google Scholar
22.Thompson, RL, Cabezudo, I, Wenzel, RP. Epidemiology of nosocomial infections caused by methicillin-resistant Staphylococcus aureus. Ann Intern Med 1982;97:309–317.Google Scholar